Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Synageva BioPharma Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Feb 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - SYNAGEVA BIOPHARMA CORP (GEVA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Feb 2015 Thomson Reuters Stock Report 11 $25.00

GEVA: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

27 Feb 2015 New Constructs, LLC 9 $25.00

ValuEngine Industry Report for Medical-biomed/genetics(GEVA)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

24 Feb 2015 ValuEngine, Inc. 10 $49.00

"The Economy Matters" Report for GEVA: the economy's impact on GEVA's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

23 Feb 2015 MacroRisk Analytics/EconomicInvestor 8 $25.00

ValuEngine Rating and Forecast Report for GEVA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

23 Feb 2015 ValuEngine, Inc. 11 $25.00

Value Graph: SYNAGEVA BIOPHAR -- GEVA

20 Feb 2015 Ford Investor Services, Inc. 1 $12.00

TheStreet.com Ratings Stock Report For: SYNAGEVA BIOPHARMA CORP (GEVA)

15 Feb 2015 TheStreet.com Ratings 5 $10.00

SYNAGEVA BIOPHM (GEVA) Zacks Company Snapshot

10 Feb 2015 Zacks Investment Research Inc. 1 $12.00

TheStreet.com Ratings Stock Report For: SYNAGEVA BIOPHARMA CORP (GEVA)

08 Feb 2015 TheStreet.com Ratings 5 $10.00